Partial Remission of Hepatic Metastatic Lesion but Complicated with Secondary and Refractory Fever Lead by Nivolumab in a Patient with Lung Adenocarcinoma Presenting Gefitinib Acquired Resistance

Detalles Bibliográficos
Autores principales: Lian, Zeng-Zhi, Sun, Yi-Feng, Chen, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819314/
https://www.ncbi.nlm.nih.gov/pubmed/26996489
http://dx.doi.org/10.4103/0366-6999.178964
_version_ 1782425178888732672
author Lian, Zeng-Zhi
Sun, Yi-Feng
Chen, Cheng
author_facet Lian, Zeng-Zhi
Sun, Yi-Feng
Chen, Cheng
author_sort Lian, Zeng-Zhi
collection PubMed
description
format Online
Article
Text
id pubmed-4819314
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-48193142016-04-05 Partial Remission of Hepatic Metastatic Lesion but Complicated with Secondary and Refractory Fever Lead by Nivolumab in a Patient with Lung Adenocarcinoma Presenting Gefitinib Acquired Resistance Lian, Zeng-Zhi Sun, Yi-Feng Chen, Cheng Chin Med J (Engl) Correspondence Medknow Publications & Media Pvt Ltd 2016-04-05 /pmc/articles/PMC4819314/ /pubmed/26996489 http://dx.doi.org/10.4103/0366-6999.178964 Text en Copyright: © 2016 Chinese Medical Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Correspondence
Lian, Zeng-Zhi
Sun, Yi-Feng
Chen, Cheng
Partial Remission of Hepatic Metastatic Lesion but Complicated with Secondary and Refractory Fever Lead by Nivolumab in a Patient with Lung Adenocarcinoma Presenting Gefitinib Acquired Resistance
title Partial Remission of Hepatic Metastatic Lesion but Complicated with Secondary and Refractory Fever Lead by Nivolumab in a Patient with Lung Adenocarcinoma Presenting Gefitinib Acquired Resistance
title_full Partial Remission of Hepatic Metastatic Lesion but Complicated with Secondary and Refractory Fever Lead by Nivolumab in a Patient with Lung Adenocarcinoma Presenting Gefitinib Acquired Resistance
title_fullStr Partial Remission of Hepatic Metastatic Lesion but Complicated with Secondary and Refractory Fever Lead by Nivolumab in a Patient with Lung Adenocarcinoma Presenting Gefitinib Acquired Resistance
title_full_unstemmed Partial Remission of Hepatic Metastatic Lesion but Complicated with Secondary and Refractory Fever Lead by Nivolumab in a Patient with Lung Adenocarcinoma Presenting Gefitinib Acquired Resistance
title_short Partial Remission of Hepatic Metastatic Lesion but Complicated with Secondary and Refractory Fever Lead by Nivolumab in a Patient with Lung Adenocarcinoma Presenting Gefitinib Acquired Resistance
title_sort partial remission of hepatic metastatic lesion but complicated with secondary and refractory fever lead by nivolumab in a patient with lung adenocarcinoma presenting gefitinib acquired resistance
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819314/
https://www.ncbi.nlm.nih.gov/pubmed/26996489
http://dx.doi.org/10.4103/0366-6999.178964
work_keys_str_mv AT lianzengzhi partialremissionofhepaticmetastaticlesionbutcomplicatedwithsecondaryandrefractoryfeverleadbynivolumabinapatientwithlungadenocarcinomapresentinggefitinibacquiredresistance
AT sunyifeng partialremissionofhepaticmetastaticlesionbutcomplicatedwithsecondaryandrefractoryfeverleadbynivolumabinapatientwithlungadenocarcinomapresentinggefitinibacquiredresistance
AT chencheng partialremissionofhepaticmetastaticlesionbutcomplicatedwithsecondaryandrefractoryfeverleadbynivolumabinapatientwithlungadenocarcinomapresentinggefitinibacquiredresistance

Ejemplares similares